IN8bio
INAB
22 hedge funds and large institutions have $3.59M invested in IN8bio in 2023 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 10 increasing their positions, 4 reducing their positions, and 2 closing their positions.
250% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 2
150% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 4
102% more capital invested
Capital invested by funds: $1.78M → $3.59M (+$1.81M)
29% more funds holding
Funds holding: 17 → 22 (+5)
0.08% more ownership
Funds ownership: 0.19% → 0.26% (+0.08%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Ensign Peak Advisors
Salt Lake City,
Utah
|
+$834K |
| 2 |
VC
Voss Capital
Houston,
Texas
|
+$250K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$247K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$162K |
| 5 |
SPC
Sigma Planning Corp
Ann Arbor,
Michigan
|
+$157K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SIG
Stonegate Investment Group
Birmingham,
Alabama
|
-$109K |
| 2 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$52.2K |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
-$14.4K |
| 4 |
RCG
Rock Creek Group
Washington,
District of Columbia
|
-$10.9K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$4.07K |
INAB Hedge Fund Activity: Q2 2023 in Review
22 of the 6,383 institutional investors tracked by Wall St. Rank reported a position in IN8bio (INAB) for Q2 2023, worth a combined $3.59M — up 102% from $1.78M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new INAB positions and 2 closed out — a net gain of 5 holders — while 10 added to existing stakes and 4 trimmed.
The largest buyer was Ensign Peak Advisors, adding an estimated $834K. The largest seller was Stonegate Investment Group, cutting an estimated $109K.
- 22 institutional investors held IN8bio (INAB) as of Q2 2023, up from 17 in Q1 2023.
- Funds reported $3.59M of IN8bio stock for Q2 2023, up 102% quarter-over-quarter.
- 7 funds opened new IN8bio positions in Q2 2023 and 2 closed out, a net change of +5 holders.
- The largest IN8bio buyer in Q2 2023 was Ensign Peak Advisors, an estimated $834K added.
- The largest IN8bio seller in Q2 2023 was Stonegate Investment Group, an estimated $109K sold.
Based on aggregated 13F filings for Q2 2023.